Inhaltsverzeichnis
Auswahl der wissenschaftlichen Literatur zum Thema „Xeroderma pigmentosum [XP]“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Xeroderma pigmentosum [XP]" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Xeroderma pigmentosum [XP]"
Tostado, Guadalupe. „Xeroderma Pigmentosum: Important Oral Manifestations Case Report“. Clinical Research and Clinical Trials 3, Nr. 1 (17.03.2021): 01–04. http://dx.doi.org/10.31579/2693-4779/023.
Der volle Inhalt der QuelleJagzape, Tushar, Arunita Bagga, Amol Gupta und Damodhar Balpande. „Xeroderma Pigmentosum A Social Stigma Report in Two Siblings and Literature Review“. Bangladesh Journal of Child Health 38, Nr. 1 (16.08.2014): 40–43. http://dx.doi.org/10.3329/bjch.v38i1.20026.
Der volle Inhalt der QuelleMahuvakar, Ankit Dilip, Vijayalaxmi Kishanrao Ambulgekar, Darshan Premdas Meshram, Shaikh Mohsin Ahmed Abdul Nabi und Mohammad A. Sammer. „A Series of Two Cases of Intraoral Malignancies in Patients with Xeroderma Pigmentosa“. An International Journal of Otorhinolaryngology Clinics 5, Nr. 2 (2013): 111–14. http://dx.doi.org/10.5005/jp-journals-10003-1122.
Der volle Inhalt der QuelleLehmann, J., C. Seebode, M. Martens und S. Emmert. „Xeroderma pigmentosum – Fakten und Perspektiven“. Aktuelle Dermatologie 44, Nr. 05 (Mai 2018): 232–36. http://dx.doi.org/10.1055/s-0043-123031.
Der volle Inhalt der QuelleBelgaumkar, Vasudha A., Ravindranath B. Chavan, Aarti S. Salunke und Pallavi P. Patil. „Xeroderma pigmentosum: a case series with ocular involvement“. International Journal of Research in Dermatology 3, Nr. 4 (23.11.2017): 545. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20175381.
Der volle Inhalt der QuelleMartens, M. C., L. Boeckmann und S. Emmert. „Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom“. Aktuelle Dermatologie 46, Nr. 08/09 (20.08.2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Der volle Inhalt der QuelleMartens, Marie Christine, Steffen Emmert und Lars Boeckmann. „Xeroderma Pigmentosum: Gene Variants and Splice Variants“. Genes 12, Nr. 8 (29.07.2021): 1173. http://dx.doi.org/10.3390/genes12081173.
Der volle Inhalt der QuelleTheron, Therina, Maria I. Fousteri, Marcel Volker, Lorna W. Harries, Elena Botta, Miria Stefanini, Mitsuo Fujimoto et al. „Transcription-Associated Breaks in Xeroderma Pigmentosum Group D Cells from Patients with Combined Features of Xeroderma Pigmentosum and Cockayne Syndrome“. Molecular and Cellular Biology 25, Nr. 18 (15.09.2005): 8368–78. http://dx.doi.org/10.1128/mcb.25.18.8368-8378.2005.
Der volle Inhalt der QuelleBootsma, D., W. Keijzer, E. G. Jung und E. Bohnert. „Xeroderma pigmentosum complementation group XP-I withdrawn“. Mutation Research/DNA Repair 218, Nr. 2 (September 1989): 149–51. http://dx.doi.org/10.1016/0921-8777(89)90021-9.
Der volle Inhalt der QuelleAl Wayli, Hessa. „Xeroderma pigmentosum and its dental implications“. European Journal of Dentistry 09, Nr. 01 (Januar 2015): 145–48. http://dx.doi.org/10.4103/1305-7456.149664.
Der volle Inhalt der QuelleDissertationen zum Thema "Xeroderma pigmentosum [XP]"
Muller, Margot. „Le syndrome Xeroderma Pigmentosum-C - étude des mécanismes moléculaires impliqués dans la prédisposition des patients XP-C aux cancers cutanés non mélanocytaire agressifs“. Electronic Thesis or Diss., Université Côte d'Azur (ComUE), 2019. http://www.theses.fr/2019AZUR6031.
Der volle Inhalt der QuelleSkin as the outer layer of the body is constantly exposed to UV, the main cause of skin cancer. Non-Melanoma Skin Cancer are divided in two cancer types: Squamous cell carcinoma (SCC) and Basal cell carcinoma (BCC). BCC arise after early acute UV exposure during childhood and present a low metastatic potential; while SCC arise after low chronic UV exposure during life time, present higher metastatic potential. Ratio between BCC and SCC is 4 to 1 in general population.In the lab, we are interested in Xeroderma Pigmentosum (XP) pathology. XP is a rare autosomal recessive genetic disease. In Europe, a large majority of XP patients carry a mutation in XPC gene. resulting in the absence of XPC protein. Canonical role of XPC is to recognize UV DNA damage and allowed DNA reparation by Nucleotide Excision Repair mechanism (NER). XP-C patients present a hypersensitivity to UV radiations and develop very early skin cancer with a higher incidence. They develop 10 000 times more non-melanoma skin cancer (NMSC) compare to general population. Interestingly, we observe that XP-C patients develop 1 BCC for 4 SCC. The objective of my PhD is to decipher the molecular mechanisms underlying XP-C keratinocytes susceptibility to SCC.In our laboratory, we used human primary keratinocytes isolated from biopsies of XP-C patients or healthy individuals. We developed a protocol to mimic chronic solar exposure by exposing primary keratinocytes to chronic low UV irradiation. We have chosen to perform an unbiased approach using whole genomic sequencing (WGS) from XP-C and WT keratinocytes exposed or non-UV exposed. As expected, chronically irradiated XP-C keratinocytes presented an increase of mutation burden particularly in coding sequence. A gene network analysis of UV mutation shows a defect in chromatin organization. Very interestingly, without UV exposure, we saw already an increase of mutation in coding sequence even though no differences in mutation burden was observed. Then performing again, a network analysis focusing only on stop mutations, we highlighted a defect in chromatin organization. These results suggested a chromatin organization defect and a more open state of chromatin in XP-C keratinocytes. Our putative model is that open chromatin could be linked to a more stem cell state of XP-C keratinocytes, suggesting a new role of XPC in chromatin organization. To validate this putative model, we mimic chromatin organisation defects by using epigenetic modifier drugs on WT primary keratinocytes. After this treatment, WT cells presented terminal differentiation defect. We then checked our XP-C keratinocytes differentiation potential. And we observed a similar phenotype to treated WT cells. XP-C keratinocytes seems to have defect in cell differentiation and cell fate commitment. We showed that XP-C keratinocytes presented a higher percentage of stem cell, a higher expression of interfollicular epidermis markers and presented a defect in terminal differentiation program. These results strongly supported our hypothesis that the absence of XP-C leads to a switch in cell identity.In conclusion, the absence of XP-C reveals a stem cell like phenotype of XP-C deficient keratinocytes with a more open chromatin that could be linked to the more aggressive type of cancer observed in patients. Indeed, the cell of origin of NMSC are different. Thus, the aggressive one has a progenitor like cell as a cell of origin. Altogether, these data correlate nicely with our putative model, giving a first clue in the explanation of the inverted ratio of NMSC cancer in XP-C pathology
Couvé-Privat, Sophie. „Etude de la voie de signalisation Sonic hedgehog dans les cancers cutanés de patients atteints de Xeroderma pigmentosum“. Paris 7, 2003. http://www.theses.fr/2003PA077149.
Der volle Inhalt der QuelleGosselet, Fabien. „Rôles et implications de la voie de signalisation Bone Morphogenetic Protein (BMP) dans les kératinocytes primaires humains normaux et issus de patients atteints de xeroderma pigmentosum de groupe D (XP-D)“. Paris 11, 2006. http://www.theses.fr/2006PA11T051.
Der volle Inhalt der QuelleZadorin, Anton. „Le complexe TFIIH dans la transcription effectuée par l'ARN polymèrase II et l'ARN polymèrase III“. Phd thesis, Université de Strasbourg, 2012. http://tel.archives-ouvertes.fr/tel-00759395.
Der volle Inhalt der QuelleSilva, Iris Alexandra Lopes da. „Molecular cloning and analysis of Xeroderma pigmentosum group-D (xpd) in zebrafish“. Master's thesis, 2011. http://hdl.handle.net/10400.1/2233.
Der volle Inhalt der QuelleBuchteile zum Thema "Xeroderma pigmentosum [XP]"
Thielmann, H. W. „Xeroderma Pigmentosum Patients from Germany (the Mannheim XP Collection): Clinical and Biochemical Characteristics“. In Skin Carcinogenesis in Man and in Experimental Models, 275–97. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-84881-0_21.
Der volle Inhalt der Quelle„17.3 Xeroderma pigmentosum (XP)“. In Dermatologie, herausgegeben von Ingrid Moll, Ernst G. Jung, Matthias Augustin, Friedrich A. Bahmer, Judith Bahmer und Christiane Bayerl. Stuttgart: Georg Thieme Verlag, 2010. http://dx.doi.org/10.1055/b-0034-86726.
Der volle Inhalt der Quelle„14.3 Xeroderma pigmentosum ( XP)“. In Dermatologie, herausgegeben von Ingrid Moll und Ernst G. Jung. Stuttgart: Georg Thieme Verlag, 2005. http://dx.doi.org/10.1055/b-0034-50093.
Der volle Inhalt der Quelle